4 hours agoThe AstraZeneca Oxyxia has an efficiency of 70%, complete data show
Periskopi(6 years ago)
(6 years ago)The AstraZeneca Oxyxia has 90 percent efficiency in small groups that get half a dose at first but only 62 percent in most have shown total data. The results may create confusion in the regulatory bodies that have to decide whether the vaccine should be used if approved, writes [...]
The results can create confusion in the regulatory bodies that have to decide whether the vaccine should be used if approved, writes The Guardian, followed Periscope.
Oxford University and its partner, AstraZeneca, are seeking approval from regulators for their long-awaited vaccine on the basis of efficiency of 70 percent.
But there are individual regulatory bodies in the United Kingdom, Europe and the US that will decide which form of dosage is appropriate.
Our research as scientists is to generate data and make it publicly accessible to people to examine, for scientists to examine dealt with, and now for regulators and policymakers to consider. These decisions are not for us,” Professor Andrew said. Pollard from Oxford University. /Periscope
